Shanghai Fosun Pharmaceutical (Group) , Ltd. Intangible Assets

Shanghai Fosun Pharmaceutical (Group) , Ltd. (600196.SS) currently reports a intangible assets of $20B as of June 2026. That compares with $20B in the prior-year period — up 1.8% year over year. Use the charts on this page to explore Shanghai Fosun Pharmaceutical (Group) , Ltd.'s intangible assets history and peer comparisons.

Shanghai Fosun Pharmaceutical (Group) , Ltd.'s intangible assets increased from $20B to $20B — a 1.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Shanghai Fosun Pharmaceutical (Group) , Ltd. reported $20B in intangible assets as of June 2026. That compares with $20B in the prior-year period — up 1.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $20B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Shanghai Fosun Pharmaceutical (Group) , Ltd., and consider following 600196.SS for alerts when major investors trade the stock.